Pfizer issues warning letter on Geodon antipsychotic drug

09/1/2004 | Forbes

The FDA and Pfizer have sent a warning letter to physicians advising them the antipsychotic drug Geodon is linked to high blood sugar and diabetes. The warning letter grew from an FDA investigation of six of the most widely used antipsychotic drugs and led to an instruction to the makers to revise their labels to reflect the dangers. The other drugs are AstraZeneca's Seroquel, Bristol-Myers Squibb's Abilify, Eli Lilly's Zyprexa, Janssen's Risperdal and Novartis' Clozaril.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park